303 related articles for article (PubMed ID: 30143922)
1. Association of serum uric acid levels with SYNTAX score II and long term mortality in the patients with stable angina pectoris who undergo percutaneous coronary interventions due to multivessel and/or unprotected left main disease.
Karabağ Y; Rencuzogullari I; Çağdaş M; Karakoyun S; Yesin M; Atalay E; Çağdaş ÖS; Gürsoy MO; Burak C; Tanboğa HI
Int J Cardiovasc Imaging; 2019 Jan; 35(1):1-7. PubMed ID: 30143922
[TBL] [Abstract][Full Text] [Related]
2. Individual Long-Term Mortality Prediction Following Either Coronary Stenting or Bypass Surgery in Patients With Multivessel and/or Unprotected Left Main Disease: An External Validation of the SYNTAX Score II Model in the 1,480 Patients of the BEST and PRECOMBAT Randomized Controlled Trials.
Sotomi Y; Cavalcante R; van Klaveren D; Ahn JM; Lee CW; de Winter RJ; Wykrzykowska JJ; Onuma Y; Steyerberg EW; Park SJ; Serruys PW
JACC Cardiovasc Interv; 2016 Aug; 9(15):1564-72. PubMed ID: 27491605
[TBL] [Abstract][Full Text] [Related]
3. Impact of hyperuricemia on clinical outcomes after percutaneous coronary intervention for in-stent restenosis.
Joo HJ; Jeong HS; Kook H; Lee SH; Park JH; Hong SJ; Yu CW; Lim DS
BMC Cardiovasc Disord; 2018 Jun; 18(1):114. PubMed ID: 29890945
[TBL] [Abstract][Full Text] [Related]
4. Association between serum uric acid level and the severity of coronary artery disease in patients with obstructive coronary artery disease.
Yu J; Han J; Mao J; Guo L; Gao W
Chin Med J (Engl); 2014; 127(6):1039-45. PubMed ID: 24622431
[TBL] [Abstract][Full Text] [Related]
5. Association of variability in uric acid and future clinical outcomes of patient with coronary artery disease undergoing percutaneous coronary intervention.
Lim SS; Yang YL; Chen SC; Wu CH; Huang SS; Chan WL; Lin SJ; Chen JW; Chou CY; Pan JP; Charng MJ; Chen YH; Wu TC; Lu TM; Hsu PF; Huang PH; Cheng HM; Huang CC; Sung SH; Lin YJ; Leu HB
Atherosclerosis; 2020 Mar; 297():40-46. PubMed ID: 32062138
[TBL] [Abstract][Full Text] [Related]
6. SYNTAX score II predicts long-term mortality in patients with one- or two-vessel disease.
Vroegindewey MM; Schuurman AS; Oemrawsingh RM; van Geuns RJ; Kardys I; Ligthart J; Daemen J; Boersma E; Serruys PW; Akkerhuis KM
PLoS One; 2018; 13(7):e0200076. PubMed ID: 29965993
[TBL] [Abstract][Full Text] [Related]
7. Elevated serum uric acid is associated with a greater inflammatory response and with short- and long-term mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Mandurino-Mirizzi A; Cornara S; Somaschini A; Demarchi A; Galazzi M; Puccio S; Montalto C; Crimi G; Ferlini M; Camporotondo R; Gnecchi M; Ferrario M; Oltrona-Visconti L; De Ferrari GM
Nutr Metab Cardiovasc Dis; 2021 Feb; 31(2):608-614. PubMed ID: 33358717
[TBL] [Abstract][Full Text] [Related]
8. Risk stratification in 3-vessel coronary artery disease: Applying the SYNTAX Score II in the Heart Team Discussion of the SYNTAX II trial.
Campos CM; Stanetic BM; Farooq V; Walsh S; Ishibashi Y; Onuma Y; Garcia-Garcia HM; Escaned J; Banning A; Serruys PW;
Catheter Cardiovasc Interv; 2015 Nov; 86(6):E229-38. PubMed ID: 25946686
[TBL] [Abstract][Full Text] [Related]
9. Impact of serum uric acid levels on the clinical prognosis and severity of coronary artery disease in patients with acute coronary syndrome and hypertension after percutaneous coronary intervention: a prospective cohort study.
Zhang S; Liu X; Song B; Yu H; Zhang X; Shao Y
BMJ Open; 2022 Jan; 12(1):e052031. PubMed ID: 35022171
[TBL] [Abstract][Full Text] [Related]
10. Comparison of multiple risk scores in assessing medium-to long-term clinical outcomes in unstable angina / non-ST-elevation myocardial infarction patients undergoing multi vessel percutaneous coronary intervention: An observational, registry-based study in India.
Sebastian G; Pillai V; Manzil A; Damodara R; Kalra I; Abdul Z; Mathew O
Indian Heart J; 2021; 73(5):555-560. PubMed ID: 34627568
[TBL] [Abstract][Full Text] [Related]
11. Impact of sex on uric acid levels and its relationship with the extent of coronary artery disease: A single-centre study.
Barbieri L; Verdoia M; Schaffer A; Marino P; Suryapranata H; De Luca G;
Atherosclerosis; 2015 Jul; 241(1):241-8. PubMed ID: 25818387
[TBL] [Abstract][Full Text] [Related]
12. Impact of non-respect of SYNTAX score II recommendation for surgery in patients with left main coronary artery disease treated by percutaneous coronary intervention: an EXCEL substudy.
Modolo R; Chichareon P; van Klaveren D; Dressler O; Zhang Y; Sabik JF; Onuma Y; Kappetein AP; Stone GW; Serruys PW
Eur J Cardiothorac Surg; 2020 Apr; 57(4):676-683. PubMed ID: 31620778
[TBL] [Abstract][Full Text] [Related]
13. Assessment of long-term mortality in patients with complex coronary artery disease undergoing percutaneous intervention: comparison of multiple anatomical and clinical prognostic risk scores.
Janella BL; Campos CM; Caixeta A; Almeida BO; Brito FS; Abizaid A; Perin MA
EuroIntervention; 2017 Nov; 13(10):1177-1184. PubMed ID: 28506936
[TBL] [Abstract][Full Text] [Related]
14. Association of the SYNTAX Score II with cardiac rupture in patients with ST-segment elevation myocardial infarction undergoing a primary percutaneous coronary intervention.
Rencuzogullari I; Çağdaş M; Karabağ Y; Karakoyun S; Yesin M; Gürsoy MO; Seyis S; Artaç İ; İliş D; Efe SÇ; Tanboğa İH
Coron Artery Dis; 2018 Mar; 29(2):97-103. PubMed ID: 29028739
[TBL] [Abstract][Full Text] [Related]
15. Coronary atherosclerotic burden assessed by SYNTAX scores and outcomes in surgical, percutaneous or medical strategies: a retrospective cohort study.
Scudeler TL; Farkouh ME; Hueb W; Rezende PC; Campolina AG; Martins EB; Godoy LC; Soares PR; Ramires JAF; Kalil Filho R
BMJ Open; 2022 Sep; 12(9):e062378. PubMed ID: 36137633
[TBL] [Abstract][Full Text] [Related]
16. Validation and comparison of the long-term prognostic capability of the SYNTAX score-II among 1,528 consecutive patients who underwent left main percutaneous coronary intervention.
Xu B; Généreux P; Yang Y; Leon MB; Xu L; Qiao S; Wu Y; Yan H; Chen J; Zhao Y; Zhao Y; Palmerini T; Stone GW; Gao R
JACC Cardiovasc Interv; 2014 Oct; 7(10):1128-37. PubMed ID: 25240551
[TBL] [Abstract][Full Text] [Related]
17. Combination of Mean Platelet Volume and Neutrophil to Lymphocyte Ratio Predicts Long-Term Major Adverse Cardiovascular Events After Percutaneous Coronary Intervention.
Choi DH; Kobayashi Y; Nishi T; Kim HK; Ki YJ; Kim SS; Park KH; Song H; Fearon WF
Angiology; 2019 Apr; 70(4):345-351. PubMed ID: 29631419
[TBL] [Abstract][Full Text] [Related]
18. Prognostic values of the SYNTAX score II and the erythrocyte sedimentation rate on long-term clinical outcomes in STEMI patients with multivessel disease: a retrospective cohort study.
Li C; Zhang Q; Wang Q; Zhong J; Wang L; Li K; Yang X
BMC Cardiovasc Disord; 2020 May; 20(1):213. PubMed ID: 32375646
[TBL] [Abstract][Full Text] [Related]
19. Predictive Performance of SYNTAX Score II in Patients With Left Main and Multivessel Coronary Artery Disease-analysis of CREDO-Kyoto registry.
Campos CM; van Klaveren D; Iqbal J; Onuma Y; Zhang YJ; Garcia-Garcia HM; Morel MA; Farooq V; Shiomi H; Furukawa Y; Nakagawa Y; Kadota K; Lemos PA; Kimura T; Steyerberg EW; Serruys PW
Circ J; 2014; 78(8):1942-9. PubMed ID: 24998278
[TBL] [Abstract][Full Text] [Related]
20. Two-year clinical outcomes in stable angina and acute coronary syndrome after percutaneous coronary intervention of left main coronary artery disease.
Hyun DY; Jeong MH; Sim DS; Jeong YA; Cho KH; Kim MC; Kim HK; Jeong HC; Park KH; Hong YJ; Kim JH; Ahn Y; Kang JC
Korean J Intern Med; 2016 Nov; 31(6):1084-1092. PubMed ID: 27756119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
